"Johnson & Johnson's Recall of Children's Tylenol and other Pediatric Medicines"

Moving Our Nation Forward

The Democratic Agenda

Improving Americans’ Quality of Life: Homes, Health, Jobs, and Education

Oversight Committee Democrats are focused on preserving home ownership, getting America back to work, ensuring quality, affordable health care, and giving all students access to a high-quality education.

Making Government Work for All Americans

Our aggressive agenda works to root out waste, fraud and abuse in government spending, enhance transparency, and ensure that the needs of Americans are put ahead of corporate special interest.

Promoting the Safety and Well-Being of the American People

We are committed to supporting our troops and veterans, protecting American consumers, and safeguarding national and homeland security.

For a PDF version of the Democratic Agenda, please click here.

What's Happening Now

Working for the American People

Cummings Issues Preliminary Findings on Executive Pay at For-Profit Colleges

Cummings Investigates Housing and Foreclosure Crisis

Cummings Investigates Potential Prescription Drug Price Gouging

Investigation of ATF's Fast and Furious Operation

Financial Crisis Inquiry Commission Report

Oil Speculation Report

Illegal Military Foreclosures Report

"Johnson & Johnson's Recall of Children's Tylenol and other Pediatric Medicines"

On Thursday, May 26, 2010, the House Committee on Oversight and Government Reform held a hearing entitled, “Johnson and Johnson’s Recall of Children’s Tylenol and Other Children’s Medicines.” The hearing examined the circumstances surrounding the voluntary recall of popular infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare.

On May 5, 2010, Chairman Towns and Ranking Member Darrell Issa (R-CA) opened the committee’s investigation into the circumstances surrounding the voluntary recall of widely used pediatric medications.Johnson & Johnson recalled 6 million bottles from over 40 different types of medicines including brands such as Children’s Tylenol, Infants’ Tylenol, Children’s Motrin, and Children’s Benadryl.

To watch a webcast of the hearing, click here

The hearing took place at 10:00 a.m. in room 2154 Rayburn House Office Building. The witnesses scheduled to testify included:

Panel I

Dr. Joshua M. Sharfstein
Principal Deputy Commissioner
U.S. Food & Drug Administration

Accompanied by:

Ms. Deborah M. Autor
Director of the Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration; and

Mr. Michael A. Chappell
Acting Associate Commissioner for Regulatory Affairs
Food and Drug Administration

Panel II

Ms. Colleen Goggins
Worldwide Chairman
Johnson & Johnson Consumer Group

Documents and Links

Opening Statement of Chairman Edolphus Towns

Prepared testimony of Dr. Joshua Sharfstein

Prepared testimony of Ms. Colleen Goggins

Closing Statement of Chairman Edolphus Towns

FDA Documents

CSCS Motrin Purchase Project Document

Committee On Oversight and Government Reform
sitemap

U.S. House of Representatives | 2471 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051